Pear Therapeutics Inc (PEARQ)

OTC Markets
Currency in USD
Disclaimer
0.0001
0.0000(0.00%)
Closed
Trading near 52-week Low
Day's Range
0.00010.0001
52 wk Range
0.00012.0900
Prev. Close
0.0001
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-2.09
Volume
679
Average Vol. (3m)
1,670,268
1-Year Change
-99.99%
Shares Outstanding
142,739,169
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about PEARQ?
Vote to see community's results!
or

Pear Therapeutics Inc Company Profile

Pear Therapeutics, Inc. is a commercial-stage healthcare company. The Company is engaged in developing a new class of software-based medicines that is referred to as prescription digital therapeutics (PDTs), which use software to treat diseases. Its products include reset, reSET-O and Somryst. The Company's reset product is indicated for the treatment of substance use disorder (SUD) related to alcohol, cannabis, cocaine and stimulants, such as monotherapy. Its reSET-O product is developed for the treatment of opioid use disorder (OUD) in combination with buprenorphine. The Company's Somryst product is the only software-based and guideline-recommended treatment for chronic insomnia. The Company’s pipeline consists of 14 product candidates, including candidates in psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal (GI), oncology, and cardiovascular. The Company focuses on psychiatric and neurologic conditions.